Search Results

Refine by Audience:

Selected filters: Scientists

Displaying 61 to 70 of 408 records
Sort by: Page: << Prev 4… 5… 6… 7… 8… 9… 10… Next >>

Journal of Nuclear Medicine Supplement Explores Nuclear Cardiology – Nov 20, 2023
A new JNM supplement highlights the exciting new developments and opportunities for nuclear cardiology in the modern era of personalized cardiovascular medicine.
SNMMI Holds Joint Workshop with FDA on PET Drug Regulations – Nov 16, 2023
On November 13 and 14, SNMMI co-hosted a workshop on PET drug manufacturing with the FDA.
Novel PET Radiotracer Facilitates Early, Noninvasive Detection of Inflammatory Bowel Disease – Nov 14, 2023
A newly developed PET radiotracer can be used to create an inflammation map of the entire gastrointestinal tract, providing detailed information to accurately detect and stage inflammatory bowel disease, according to research published in JNM.
Bone Scans Overstage Prostate Cancer at Initial Staging Compared with PSMA PET – Nov 9, 2023
Bone scans have been found to overstage prostate cancer at initial staging compared to PSMA PET, according to new research published in JNM.
SNMMI Dinner Symposium: How PSMA Imaging and Therapy are Changing Care for Prostate Cancer Patients - Denver, CO – Nov 3, 2023
SNMMI Dinner Symposium: How PSMA Imaging and Therapy are Changing Care for Prostate Cancer Patients (November 9, 2023, Denver, CO)
SNMMI Statement on Israel and Gaza – Oct 18, 2023
The Society of Nuclear Medicine and Molecular Imaging strongly condemns the recent terrorism in Israel and war in Gaza.
New AI Tool for PET Imaging Allows for High-Quality, Fully Automated Evaluation of Brain Tumors – Oct 17, 2023
A new artificial intelligence tool provides a fully automated, easy-to-use and objective way to detect and evaluate brain tumors, according to new research published in JNM.
CMS Removes NCD for Beta Amyloid PET – Oct 13, 2023
CMS announced today the removal of the NCD for beta-amyloid PET scans, expanding access for patients with Alzheimer's disease and other neurodegenerative diseases.
PET Imaging Validates Use of Common Cholesterol Drug to Enhance HER2-Targeted Cancer Therapy – Oct 12, 2023
A novel therapeutic approach combining HER2-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth, according to research published in JNM.
Message from the President – Oct 10, 2023
SNMMI President Helen Nadel highlights recent achievements, global collaborations, advocacy efforts, and upcoming SNMMI meetings.

Displaying 61 to 70 of 408 records
Page: << Prev 4… 5… 6… 7… 8… 9… 10… Next >>